Acute MI Nursing Diagnosis: Comprehensive Guide for Healthcare Professionals

Introduction

Acute Myocardial Infarction (MI), commonly known as a heart attack, remains a critical health concern and a leading cause of mortality worldwide. Globally, millions are affected by this condition, with significant mortality rates reported annually, particularly in developed nations. Acute MI is broadly classified into two primary types: ST-segment elevation MI (STEMI) and non-ST-segment elevation MI (NSTEMI). Unstable angina shares similarities with NSTEMI but is distinguished by the absence of elevated cardiac markers. Understanding the nuances of acute MI, particularly from a nursing perspective, is crucial for timely intervention and improved patient outcomes. This article delves into the essential aspects of acute MI, with a specific focus on nursing diagnoses, to equip healthcare professionals with the knowledge necessary for effective patient care.

Myocardial infarction occurs when there is an interruption of blood supply to a part of the heart, causing irreversible damage to the heart muscle due to oxygen deprivation. This ischemic event can lead to both diastolic and systolic dysfunction, predisposing patients to cardiac arrhythmias and other severe complications. The cornerstone of managing acute MI is prompt reperfusion of the heart to restore blood flow. Early treatment, ideally within six hours of symptom onset, is paramount for improving prognosis and minimizing myocardial damage.

The diagnosis of an MI is typically established when at least two of the following criteria are present:

1. Clinical symptoms indicative of ischemia, such as chest pain or discomfort.
2. Electrocardiogram (ECG) changes, including new ST-segment deviations or a new left bundle branch block (LBBB).
3. Development of pathological Q waves on the ECG, signifying myocardial necrosis.
4. Imaging evidence of new regional wall motion abnormalities, indicating impaired heart function.
5. Identification of an intracoronary thrombus during autopsy or angiography, confirming vessel occlusion.

Specimen of Myocardial Infarction: Illustrating damage to the left ventricle and interventricular septum, a key area affected during an MI. The asterisk denotes left ventricular hypertrophy.

Essential Nursing Diagnoses for Acute Myocardial Infarction

Nurses play a pivotal role in the care of patients experiencing acute MI. Accurate nursing diagnoses are essential for guiding interventions and achieving positive patient outcomes. The following are key nursing diagnoses frequently associated with acute MI:

• Acute Pain: Related to myocardial ischemia and tissue necrosis, often manifested as chest pain, discomfort, or pressure.
• Activity Intolerance: Related to decreased cardiac output and oxygen supply, leading to fatigue and weakness during physical exertion.
• Fear/Anxiety: Related to the life-threatening nature of the event, pain, and uncertainty about prognosis and future health status.
• Risk for Decreased Cardiac Output: Related to myocardial damage and impaired contractility, potentially leading to hemodynamic instability.
• Risk for Ineffective Tissue Perfusion (Cardiac, Peripheral, Cerebral): Related to reduced blood flow secondary to myocardial infarction and potential complications like cardiogenic shock.
• Risk for Excess Fluid Volume: Related to potential heart failure and fluid retention due to impaired cardiac function.
• Deficient Knowledge: Related to lack of understanding of the condition, treatment plan, risk factor modification, and rehabilitation.

Causes of Acute Myocardial Infarction

The primary cause of acute myocardial infarction is a significant reduction in coronary blood flow. This imbalance between oxygen supply and demand leads to myocardial ischemia and subsequent infarction if blood flow is not promptly restored. The most common underlying cause of reduced coronary blood flow is the rupture of atherosclerotic plaques.

Atherosclerosis and Thrombosis

Atherosclerotic plaques, built up over time within the coronary arteries, can become unstable and rupture. This rupture triggers the formation of a thrombus (blood clot) at the site of the plaque. This thrombus can acutely obstruct coronary blood flow, leading to severe ischemia and myocardial infarction. Atherosclerosis is responsible for the majority of acute MIs.

Less Common Etiologies

While atherosclerosis is the predominant cause, other less frequent etiologies can also lead to acute MI:

• Coronary Artery Embolism: Emboli, or traveling clots, can originate from other parts of the body and lodge in the coronary arteries, causing blockage. This accounts for a small percentage of MI cases.
• Cocaine-Induced Ischemia: Cocaine use can induce coronary artery vasospasm and increase myocardial oxygen demand, leading to ischemia and infarction, particularly in younger individuals.
• Coronary Artery Dissection: A tear in the inner layer of a coronary artery can obstruct blood flow and cause MI. This is less common but can occur spontaneously or be associated with certain conditions.
• Coronary Vasospasm: Spasms of the coronary arteries can temporarily reduce or block blood flow, leading to ischemia and potentially infarction, even in the absence of significant atherosclerosis.

Risk Factors for Myocardial Infarction

Identifying and managing risk factors is crucial in preventing acute myocardial infarction. Atherosclerosis is the major underlying pathology in most MI cases, and therefore, risk factors for atherosclerosis are also primary risk factors for MI. Notably, modifiable risk factors are responsible for a large majority of myocardial infarctions.

Modifiable Risk Factors

These are risk factors that can be changed through lifestyle modifications and medical management:

• Cigarette Smoking: Smoking significantly increases the risk of atherosclerosis and MI.
• Physical Inactivity: Lack of regular exercise contributes to several other risk factors, including obesity, hypertension, and dyslipidemia.
• Hypertension: High blood pressure puts increased strain on the heart and arteries, accelerating atherosclerosis.
• Obesity: Excess body weight, particularly abdominal obesity, is linked to insulin resistance, hypertension, and dyslipidemia, all contributing to increased MI risk.
• Dyslipidemia: Abnormal cholesterol levels, including high LDL (“bad” cholesterol) and triglyceride levels, and low HDL (“good” cholesterol), promote atherosclerosis.
• Diabetes Mellitus: Diabetes significantly increases the risk of cardiovascular disease, including MI, due to its effects on blood vessels and lipid metabolism.

Non-Modifiable Risk Factors

These risk factors cannot be changed but are important to consider in risk assessment:

• Age: The risk of MI increases with age.
• Sex: Men generally have a higher risk of MI at younger ages compared to women, although women’s risk increases significantly after menopause.
• Family History: A family history of premature coronary artery disease increases individual risk.

Assessment of Acute Myocardial Infarction

A thorough assessment is crucial for the timely recognition and management of acute MI. The patient history and physical examination are vital components, although they can sometimes be inconsistent in presentation.

History Taking

The patient history should focus on:

• Onset of Symptoms: When did the chest pain or discomfort begin? Was it sudden or gradual?
• Quality of Pain: How would you describe the pain? (e.g., crushing, squeezing, tight, burning).
• Location and Radiation: Where is the pain located? Does it radiate to the arm, jaw, back, or shoulder?
• Associated Symptoms: Are there any other symptoms accompanying the chest pain? (e.g., shortness of breath, nausea, sweating, dizziness).

Recent studies indicate that diaphoresis (sweating) and bilateral arm pain radiating pain are strongly associated with myocardial infarction, especially in men. Other associated symptoms may include:

• Lightheadedness or dizziness
• Anxiety or a sense of impending doom
• Cough
• Choking sensation
• Diaphoresis (sweating)
• Wheezing
• Irregular heart rate or palpitations

Physical Examination

The physical examination should focus on:

• Vital Signs: Assess heart rate, blood pressure, respiratory rate, and temperature.
• General Appearance: Note the patient’s overall condition, including signs of distress, diaphoresis, and anxiety.
• Respiratory System: Auscultate lung sounds for any abnormalities, such as wheezing or rales (crackles), which may indicate pulmonary edema.
• Cardiovascular System:
  • Heart Rate and Rhythm: Assess for tachycardia, bradycardia, atrial fibrillation, or other arrhythmias.
  • Pulses: Check for unequal pulses, which may suggest aortic dissection.
  • Blood Pressure: Note if blood pressure is elevated, normal, or low (hypotension, suggesting shock).
  • Jugular Venous Distention (JVD): Assess for JVD, which may indicate right ventricular failure.
  • Cardiac Auscultation: Listen for heart sounds. Findings may include:
    • Soft S1 sound
    • Palpable S4 gallop sound
    • New mitral regurgitation murmur
    • Loud holosystolic murmur radiating to the sternum (may indicate ventricular septal rupture, a serious complication).
• Extremities: Assess for edema, cyanosis (bluish discoloration), and temperature (cold extremities).

Evaluation and Diagnostic Tests for Acute Myocardial Infarction

Prompt and accurate diagnosis of acute MI is critical. Electrocardiography (ECG) and cardiac biomarkers are the primary diagnostic tools.

Electrocardiogram (ECG)

An ECG should be performed immediately on any patient presenting with chest pain or symptoms suggestive of MI. It is a highly specific test for MI but less sensitive, meaning it is good at confirming MI when present but may not always detect it in early stages or in all types of MI.

• ECG Findings in STEMI: ST-segment elevation in two or more contiguous leads is the hallmark of STEMI. Specific lead groupings correlate with different areas of the heart:
  • Inferior MI: Leads II, III, aVF
  • Septal MI: Leads V1, V2
  • Anterior MI: Leads V3, V4
  • Lateral MI: Leads I, aVL, V5, V6
  • Reciprocal ST depressions may be seen in opposite anatomical regions.
• Hyperacute T Waves: Peaked T waves, known as “hyperacute T waves,” can be an early ECG finding indicating ischemia and may precede ST-segment elevation.
• ECG in NSTEMI and Unstable Angina: Patients with NSTEMI or unstable angina may have ECG changes such as ST-segment depression, T wave inversions, or may have a normal ECG. Serial ECGs can be helpful in detecting dynamic changes over time.
• Challenges in ECG Interpretation: Diagnosing STEMI can be more complex in patients with pre-existing conditions such as left bundle branch block (LBBB) or in patients with pacemakers. Specific criteria like Sgarbosa’s criteria help in these situations. Isolated ST-elevation in aVR may indicate left main coronary artery occlusion. Wellens’ waves (deeply biphasic T waves in V2, V3) are associated with proximal left anterior descending artery occlusion risk.
• Women and Elderly Patients: It’s important to note that women and elderly patients may present with atypical symptoms. Women may experience abdominal pain, dizziness, or fatigue without classic chest pain. Elderly patients may present primarily with shortness of breath. In these populations, ECG testing should be considered even with atypical presentations.

ECG with Pardee Waves: Demonstrating ST-segment elevation and Pardee waves in inferior leads (II, III, aVF), indicative of acute myocardial infarction.

Cardiac Biomarkers

Cardiac troponins are the preferred biomarkers for diagnosing myocardial infarction. Troponins are proteins released into the bloodstream when myocardial damage occurs.

• Troponin Levels: Elevated troponin levels are highly sensitive and specific for myocardial injury. Serial measurements are often performed to assess the trend in troponin levels.
• Timing of Troponin Measurement: Troponins may not be elevated immediately after symptom onset. It can take several hours for troponin levels to rise. Therefore, repeat measurements are typically drawn over a period of 3-6 hours, and sometimes up to 12-24 hours, depending on the clinical scenario and initial results.
• Other Laboratory Tests: While troponins are the primary biomarker, other laboratory tests may be ordered as part of the overall evaluation:
  • Complete Blood Count (CBC)
  • Lipid Profile
  • Renal Function Tests
  • Metabolic Panel

Risk Scoring Systems

Risk scoring systems, such as the HEART score, can help clinicians assess the likelihood of acute coronary syndrome (ACS) and guide further management decisions, particularly in patients with NSTEMI or unstable angina. The HEART score incorporates factors such as:

• History: Patient’s clinical history and symptom description.
• ECG: ECG findings.
• Age: Patient’s age.
• Risk Factors: Presence of cardiovascular risk factors.
• Troponin: Initial troponin level.

Based on the HEART score, patients are categorized into low, intermediate, or high risk, which helps determine the need for further investigations and interventions.

Medical Management of Acute Myocardial Infarction

The immediate goals of medical management in acute MI are to relieve pain, restore coronary blood flow (reperfusion), and prevent complications.

Initial Measures for All Patients

Regardless of the type of MI (STEMI or NSTEMI), initial management includes:

• Aspirin: Immediate administration of chewable aspirin (160-325 mg) to inhibit platelet aggregation and reduce thrombus formation.
• Oxygen Therapy: Supplemental oxygen if oxygen saturation is below 91%.
• Intravenous Access: Establish intravenous (IV) access for medication administration.
• Pain Management: Opioid analgesics (e.g., morphine) may be used for pain relief, along with sublingual nitroglycerin (if blood pressure is adequate).

Management of STEMI (ST-Elevation Myocardial Infarction)

The primary treatment strategy for STEMI is immediate reperfusion therapy to restore blood flow to the blocked coronary artery.

• Percutaneous Coronary Intervention (PCI): Primary PCI is the preferred reperfusion strategy if it can be performed within 90 minutes of first medical contact (“door-to-balloon time”). PCI involves inserting a catheter into the coronary artery and using a balloon and stent to open the blocked vessel.
  • Antithrombotic Therapy During PCI: Prior to PCI, patients typically receive dual antiplatelet therapy (DAPT) with aspirin and a P2Y12 inhibitor (e.g., ticagrelor, clopidogrel, prasugrel), and anticoagulation with intravenous heparin. Glycoprotein IIb/IIIa inhibitors or direct thrombin inhibitors may also be used during PCI in certain situations.
• Fibrinolytic Therapy (Thrombolysis): If PCI cannot be performed within the recommended timeframe (e.g., in settings without PCI capability or significant delays), fibrinolytic therapy (thrombolytics or “clot-busters”) is indicated, ideally within 120 minutes of symptom onset. Fibrinolytics dissolve the thrombus and restore blood flow. After fibrinolysis, patients are typically transferred to a PCI-capable center for further management.

Management of NSTEMI (Non-ST-Elevation Myocardial Infarction)

Management of NSTEMI depends on the patient’s risk stratification.

• Medical Management and Antiplatelet Therapy: Stable, asymptomatic NSTEMI patients may be initially managed medically with antiplatelet agents (aspirin and a P2Y12 inhibitor) and anticoagulation.
• Early Invasive Strategy (PCI): For NSTEMI patients with ongoing ischemia, hemodynamic instability, or high-risk features, an early invasive strategy with PCI within 48 hours of admission is generally recommended. PCI in these cases can improve outcomes, reduce in-hospital mortality, and shorten hospital stay.
• Medications at Discharge: Before discharge, patients post-MI are typically prescribed several medications to prevent recurrent events and improve long-term outcomes, often including:
  • Aspirin (lifelong)
  • P2Y12 inhibitor (for a period, typically 12 months)
  • High-dose statin (to lower cholesterol)
  • Beta-blocker (to reduce heart rate and blood pressure)
  • ACE inhibitor or ARB (especially in patients with heart failure, hypertension, or diabetes)

Nursing Management of Acute Myocardial Infarction

Nurses are integral to the care of patients with acute MI, from initial assessment and stabilization to ongoing monitoring and education.

Key Nursing Interventions

• Continuous ECG Monitoring: Obtain and monitor ECGs daily and as needed to detect changes in rhythm or ST segments.
• Establish IV Access: Ensure the patient has at least two large-bore IV lines for medication and fluid administration.
• Monitor Cardiac Enzymes: Monitor serial cardiac enzyme levels (troponins) as ordered.
• Implement Acute MI Treatment Protocols: Initiate and follow established protocols for acute MI management, including medication administration and reperfusion strategies.
• Pain Management: Administer pain medications, such as morphine, as ordered, and assess pain relief effectiveness.
• Administer Medications: Administer aspirin, nitroglycerin, antiplatelet agents, anticoagulants, beta-blockers, ACE inhibitors, and other medications as prescribed.
• Oxygen Administration: Provide supplemental oxygen if pulse oximetry is less than 94% on room air.
• Cardiology Consultation: Ensure timely consultation with a cardiologist.
• Hemodynamic Monitoring: Monitor vital signs (heart rate, blood pressure, respiratory rate, temperature), daily weights, and urine output closely.
• Anticoagulation Management: Administer heparin or other anticoagulants as ordered, especially for STEMI patients.
• Post-Cardiac Catheterization Care: For patients undergoing cardiac catheterization or PCI, monitor the groin insertion site for hematoma or bleeding and assess distal leg pulses to ensure adequate circulation.

When to Seek Immediate Help

Patients and healthcare providers should be vigilant for signs and symptoms that warrant immediate medical attention in the context of potential or confirmed MI. These include:

• Hypotension (low blood pressure)
• Nausea and vomiting
• Continuing or worsening chest pain or discomfort
• Loss of distal leg pulses (could indicate emboli or severe circulatory compromise)
• Sudden change in mental status or confusion
• Persistent oxygen desaturation (low oxygen levels)
• Tachycardia or new onset arrhythmias
• Sudden onset of a loud heart murmur (may indicate new mitral regurgitation or ventricular rupture)

Outcome Identification and Goals of Care

The primary goals of nursing care for patients with acute MI are to:

• Improve Breathing: Optimize respiratory function and oxygenation.
• Relieve Chest Pain: Effectively manage and alleviate chest pain and discomfort.
• Improve Tissue Perfusion: Restore and maintain adequate cardiac and systemic tissue perfusion.
• Regain Functional Capacity: Support the patient in regaining pre-MI functional status and quality of life.

Monitoring and Ongoing Assessment

Continuous monitoring is essential to detect complications and evaluate treatment effectiveness. Key monitoring parameters include:

• ECG Monitoring: Continuous or frequent ECG monitoring for rhythm changes and ischemia.
• Cardiac Biomarkers: Serial monitoring of cardiac enzyme levels (troponins).
• Oxygenation Status: Continuous pulse oximetry.
• Vital Signs: Frequent monitoring of heart rate, blood pressure, respiratory rate.
• Pain Assessment: Regularly assess the intensity and characteristics of chest pain.
• Peripheral Circulation: Palpate and assess leg pulses.
• Auscultation of Lungs and Heart: Auscultate chest for rales (crackles) and new heart murmurs.

Coordination of Interprofessional Care

Optimal management of acute myocardial infarction requires a collaborative, interprofessional team approach. The core team typically includes:

• Cardiologist: Leads the overall medical management, including diagnosis, reperfusion strategies, and medication management.
• Cardiac Surgeon: May be involved in complex cases or complications requiring surgical intervention.
• Interventional Cardiologist: Performs PCI procedures.
• Intensivist/Critical Care Physician: Manages critically ill patients in the intensive care unit (ICU).
• Cardiac Rehabilitation Specialist: Develops and oversees cardiac rehabilitation programs.
• Critical Care or Cardiology Nurses: Provide specialized nursing care, monitoring, and medication administration.
• Pharmacist: Reviews medications, checks for drug interactions, and provides patient education on medications.
• Physical Therapist: Assists with early mobilization and rehabilitation.
• Social Worker: Provides psychosocial support, assists with discharge planning, and connects patients with community resources.

Patient Education and Discharge Planning

Patient education is vital for improving outcomes and preventing recurrent events. Education should focus on:

• Medication Management: Importance of medication adherence, proper dosing, and potential side effects.
• Risk Factor Modification: Lifestyle changes to reduce risk factors, including smoking cessation, healthy diet, weight management, and regular exercise.
• Cardiac Rehabilitation: Encouraging participation in a cardiac rehabilitation program.
• Warning Signs and Symptoms: Educating patients on recognizing symptoms of angina or recurrent MI and when to seek immediate medical attention.
• Follow-up Care: Importance of regular follow-up appointments with their healthcare provider.

Myocardial Infarction Warning Signs in Women: Illustrating common and atypical symptoms of heart attack in women, emphasizing the need for awareness.

Outcomes and Prognosis

Despite advances in treatment, acute myocardial infarction remains a serious condition with significant morbidity and mortality.

• Mortality Rates: A significant proportion of patients die before reaching the hospital, and mortality remains elevated in the first year after MI.
• Readmission Rates: Readmission rates are also substantial within the first year after MI.
• Prognostic Factors: Prognosis is influenced by factors such as left ventricular ejection fraction, age, comorbidities, and timely reperfusion. Patients who undergo early and successful reperfusion and have preserved left ventricular function generally have the best outcomes.

Health Teaching and Health Promotion

Preventive strategies and health education are essential for reducing the incidence and impact of acute MI. Key health promotion messages include:

• Healthy Diet: Emphasize a heart-healthy, low-salt diet rich in fruits, vegetables, and whole grains.
• Medication Compliance: Stress the importance of taking prescribed medications as directed.
• Weight Management: Maintain a healthy body weight.
• Physical Activity: Engage in regular physical activity and consider enrolling in cardiac rehabilitation.
• Risk Factor Control: Manage blood pressure, blood sugar, and lipid levels.
• Smoking Cessation: Avoid smoking and seek help to quit if needed.
• Regular Follow-up: Maintain regular check-ups with healthcare providers.

Risk Management Strategies

Effective risk management is crucial for both preventing initial MI and reducing the risk of recurrence. Key strategies include:

• Promptly Address Chest Pain: Advise individuals not to ignore chest pain and to seek medical attention immediately.
• Vital Sign Monitoring: If vital signs are abnormal, ensure prompt referral to a cardiologist.
• Laboratory Monitoring: If laboratory parameters are abnormal, consult with a physician urgently.

Discharge Planning Considerations

Discharge planning should be comprehensive and patient-centered, focusing on:

• Dietary Recommendations: Reinforce healthy eating habits.
• Activity and Exercise: Encourage ambulation and increased physical activity.
• Medication Adherence: Review medication regimens and ensure patient understanding.
• Follow-up Appointments: Schedule follow-up appointments with healthcare providers.
• Smoking Cessation Support: Provide ongoing support for smoking cessation.

Evidence-Based Nursing Practice

Evidence consistently demonstrates that early treatment of MI significantly improves prognosis. Nurses play a crucial role in early recognition of symptoms and ensuring timely intervention. Reducing modifiable risk factors is also a key evidence-based strategy for improving outcomes in patients at risk for or with established coronary artery disease.

Conclusion

Acute myocardial infarction is a life-threatening condition requiring prompt recognition, effective nursing care, and collaborative interprofessional management. Nurses are at the forefront of patient care, playing a critical role in assessment, diagnosis, intervention, monitoring, and education. By understanding the key nursing diagnoses associated with acute MI and implementing evidence-based practices, nurses can significantly contribute to improved patient outcomes and quality of life following a myocardial infarction.

References

1.Nascimento BR, Brant LCC, Marino BCA, Passaglia LG, Ribeiro ALP. Implementing myocardial infarction systems of care in low/middle-income countries. Heart. 2019 Jan;105(1):20-26. [PubMed: 30269080]

2.Barberi C, van den Hondel KE. The use of cardiac troponin T (cTnT) in the postmortem diagnosis of acute myocardial infarction and sudden cardiac death: A systematic review. Forensic Sci Int. 2018 Nov;292:27-38. [PubMed: 30269044]

3.Alaour B, Liew F, Kaier TE. Cardiac Troponin – diagnostic problems and impact on cardiovascular disease. Ann Med. 2018 Dec;50(8):655-665. [PubMed: 30265127]

4.Massberg S, Polzin A. [Update ESC-Guideline 2017: Dual Antiplatelet Therapy]. Dtsch Med Wochenschr. 2018 Aug;143(15):1090-1093. [PubMed: 30060279]

5.Scheen AJ. [From atherosclerosis to atherothrombosis : from a silent chronic pathology to an acute critical event]. Rev Med Liege. 2018 May;73(5-6):224-228. [PubMed: 29926559]

6.Berg DD, Wiviott SD, Braunwald E, Guo J, Im K, Kashani A, Gibson CM, Cannon CP, Morrow DA, Bhatt DL, Mega JL, O’Donoghue ML, Antman EM, Newby LK, Sabatine MS, Giugliano RP. Modes and timing of death in 66 252 patients with non-ST-segment elevation acute coronary syndromes enrolled in 14 TIMI trials. Eur Heart J. 2018 Nov 07;39(42):3810-3820. [PMC free article: PMC6220126] [PubMed: 30239711]

7.Deng D, Liu L, Xu G, Gan J, Shen Y, Shi Y, Zhu R, Lin Y. Epidemiology and Serum Metabolic Characteristics of Acute Myocardial Infarction Patients in Chest Pain Centers. Iran J Public Health. 2018 Jul;47(7):1017-1029. [PMC free article: PMC6119561] [PubMed: 30182001]

8.Haig C, Carrick D, Carberry J, Mangion K, Maznyczka A, Wetherall K, McEntegart M, Petrie MC, Eteiba H, Lindsay M, Hood S, Watkins S, Davie A, Mahrous A, Mordi I, Ahmed N, Teng Yue May V, Ford I, Radjenovic A, Welsh P, Sattar N, Oldroyd KG, Berry C. Current Smoking and Prognosis After Acute ST-Segment Elevation Myocardial Infarction: New Pathophysiological Insights. JACC Cardiovasc Imaging. 2019 Jun;12(6):993-1003. [PMC free article: PMC6547246] [PubMed: 30031700]

9.Alquézar-Arbé A, Sanchís J, Guillén E, Bardají A, Miró Ò, Ordóñez-Llanos J. Cardiac troponin measurement and interpretation in the diagnosis of acute myocardial infarction in the emergency department: a consensus statement. Emergencias. 2018 Oct;30(5):336-349. [PubMed: 30260119]

10.Perera M, Aggarwal L, Scott IA, Logan B. Received care compared to ADP-guided care of patients admitted to hospital with chest pain of possible cardiac origin. Int J Gen Med. 2018;11:345-351. [PMC free article: PMC6128279] [PubMed: 30214268]

11.Riley RF, Miller CD, Russell GB, Soliman EZ, Hiestand BC, Herrington DM, Mahler SA. Usefulness of Serial 12-Lead Electrocardiograms in Predicting 30-Day Outcomes in Patients With Undifferentiated Chest Pain (the ASAP CATH Study). Am J Cardiol. 2018 Aug 01;122(3):374-380. [PubMed: 30196932]

12.Jneid H, Addison D, Bhatt DL, Fonarow GC, Gokak S, Grady KL, Green LA, Heidenreich PA, Ho PM, Jurgens CY, King ML, Kumbhani DJ, Pancholy S. 2017 AHA/ACC Clinical Performance and Quality Measures for Adults With ST-Elevation and Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures. J Am Coll Cardiol. 2017 Oct 17;70(16):2048-2090. [PubMed: 28943066]

13.Larson EA, German DM, Shatzel J, DeLoughery TG. Anticoagulation in the cardiac patient: A concise review. Eur J Haematol. 2019 Jan;102(1):3-19. [PubMed: 30203452]

14.Bath PM, Woodhouse LJ, Appleton JP, Beridze M, Christensen H, Dineen RA, Flaherty K, Duley L, England TJ, Havard D, Heptinstall S, James M, Kasonde C, Krishnan K, Markus HS, Montgomery AA, Pocock S, Randall M, Ranta A, Robinson TG, Scutt P, Venables GS, Sprigg N. Triple versus guideline antiplatelet therapy to prevent recurrence after acute ischaemic stroke or transient ischaemic attack: the TARDIS RCT. Health Technol Assess. 2018 Aug;22(48):1-76. [PMC free article: PMC6139477] [PubMed: 30179153]

15.Adamski P, Adamska U, Ostrowska M, Navarese EP, Kubica J. Evaluating current and emerging antithrombotic therapy currently available for the treatment of acute coronary syndrome in geriatric populations. Expert Opin Pharmacother. 2018 Sep;19(13):1415-1425. [PubMed: 30132731]

16.Stone GW, Ellis SG, Gori T, Metzger DC, Stein B, Erickson M, Torzewski J, Williams J, Lawson W, Broderick TM, Kabour A, Piegari G, Cavendish J, Bertolet B, Choi JW, Marx SO, Généreux P, Kereiakes DJ., ABSORB IV Investigators. Blinded outcomes and angina assessment of coronary bioresorbable scaffolds: 30-day and 1-year results from the ABSORB IV randomised trial. Lancet. 2018 Oct 27;392(10157):1530-1540. [PubMed: 30266412]

17.Lopes RD, de Barros E Silva PGM, de Andrade Jesuíno I, Santucci EV, Barbosa LM, Damiani LP, Nakagawa Santos RH, Laranjeira LN, Dall Orto FTC, Beraldo de Andrade P, de Castro Bienert IR, Alexander JH, Granger CB, Berwanger O. Timing of Loading Dose of Atorvastatin in Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndromes: Insights From the SECURE-PCI Randomized Clinical Trial. JAMA Cardiol. 2018 Nov 01;3(11):1113-1118. [PMC free article: PMC6583055] [PubMed: 30264159]

18.Choi AR, Jeong MH, Hong YJ, Sohn SJ, Kook HY, Sim DS, Ahn YK, Lee KH, Cho JY, Kim YJ, Cho MC, Kim CJ., other Korea Acute Myocardial Infarction Registry Investigators. Clinical characteristics and outcomes in acute myocardial infarction patients with versus without any cardiovascular risk factors. Korean J Intern Med. 2019 Sep;34(5):1040-1049. [PMC free article: PMC6718753] [PubMed: 30257551]

19.Piotrowicz R, Wolszakiewicz J. Cardiac rehabilitation following myocardial infarction. Cardiol J. 2008;15(5):481-7. [PubMed: 18810728]

20.Ruano-Ravina A, Pena-Gil C, Abu-Assi E, Raposeiras S, van ‘t Hof A, Meindersma E, Bossano Prescott EI, González-Juanatey JR. Participation and adherence to cardiac rehabilitation programs. A systematic review. Int J Cardiol. 2016 Nov 15;223:436-443. [PubMed: 27557484]

21.Contractor AS. Cardiac rehabilitation after myocardial infarction. J Assoc Physicians India. 2011 Dec;59 Suppl:51-5. [PubMed: 22624283]

22.Sjölin I, Bäck M, Nilsson L, Schiopu A, Leosdottir M. Association between attending exercise-based cardiac rehabilitation and cardiovascular risk factors at one-year post myocardial infarction. PLoS One. 2020;15(5):e0232772. [PMC free article: PMC7213725] [PubMed: 32392231]

23.Aeyels D, Seys D, Sinnaeve PR, Claeys MJ, Gevaert S, Schoors D, Sermeus W, Panella M, Bruyneel L, Vanhaecht K. Managing in-hospital quality improvement: An importance-performance analysis to set priorities for ST-elevation myocardial infarction care. Eur J Cardiovasc Nurs. 2018 Aug;17(6):535-542. [PubMed: 29448818]

24.Schwaab B. [Cardiac Rehabilitation]. Rehabilitation (Stuttg). 2018 Apr;57(2):117-126. [PubMed: 29216666]

25.El Hajj MS, Jaam MJ, Awaisu A. Effect of pharmacist care on medication adherence and cardiovascular outcomes among patients post-acute coronary syndrome: A systematic review. Res Social Adm Pharm. 2018 Jun;14(6):507-520. [PubMed: 28641999]

Disclosure: Oren Mechanic declares no relevant financial relationships with ineligible companies.

Disclosure: Michael Gavin declares no relevant financial relationships with ineligible companies.

Disclosure: Shamai Grossman declares no relevant financial relationships with ineligible companies.

Disclosure: Kim Ziegler declares no relevant financial relationships with ineligible companies.